DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 211 filers reported holding DENALI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 4.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $476 | +81.0% | 23,089 | +102.1% | 0.05% | +100.0% |
| Q1 2023 | $263 | -99.9% | 11,423 | +60.0% | 0.02% | +9.1% |
| Q3 2022 | $219,000 | -59.6% | 7,140 | -41.3% | 0.02% | -63.3% |
| Q4 2021 | $542,000 | +44.5% | 12,160 | +85.1% | 0.06% | +42.9% |
| Q1 2021 | $375,000 | -5.5% | 6,570 | -61.6% | 0.04% | -35.4% |
| Q1 2019 | $397,000 | +91.8% | 17,104 | +25.9% | 0.06% | +109.7% |
| Q2 2018 | $207,000 | – | 13,585 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
| Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
| Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
| Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
| SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
| Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
| GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
| BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |